Understanding Inflammatory Arthritis in Cancer Patients Caused by Checkpoint Inhibitors

A new registry at HSS is following cancer patients who’ve developed inflammatory arthritis as a result of treatment with checkpoint inhibitors. The research is helping clinicians understand how to treat this condition without interfering with the anticancer effects of therapy. Hear from rheumatologists Anne Bass, MD, and Karmela Chan, MD, on the goals of the registry and what they hope to learn.

CONNECT WITH HSS